Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experience

OBJECTIVE: To develop, test, and iterate a comprehensive neuromuscular targeted gene panel in a national referral center. METHODS: We designed two iterations of a comprehensive targeted gene panel for neuromuscular disorders. Version 1 included 336 genes, which was increased to 464 genes in Version...

Descripción completa

Detalles Bibliográficos
Autores principales: Beecroft, Sarah J., Yau, Kyle S., Allcock, Richard J. N., Mina, Kym, Gooding, Rebecca, Faiz, Fathimath, Atkinson, Vanessa J., Wise, Cheryl, Sivadorai, Padma, Trajanoski, Daniel, Kresoje, Nina, Ong, Royston, Duff, Rachael M., Cabrera‐Serrano, Macarena, Nowak, Kristen J., Pachter, Nicholas, Ravenscroft, Gianina, Lamont, Phillipa J., Davis, Mark R., Laing, Nigel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086001/
https://www.ncbi.nlm.nih.gov/pubmed/32153140
http://dx.doi.org/10.1002/acn3.51002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086001/
https://www.ncbi.nlm.nih.gov/pubmed/32153140
http://dx.doi.org/10.1002/acn3.51002

Ejemplares similares